Nootropics Index - Save on smarter supplements
Vitamins & vitamin-like compounds

Nicotinamide Riboside

Nicotinamide Riboside (nicotinamide riboside / vitamin B3 derivative)

Nicotinamide riboside (NR) is a nicotinamide-derived NAD precursor; for a useful product comparison, compare the exact NR salt, studied amount, trial duration, and safety monitoring rather than relying on “cellular energy” claims.

Water SolubleClinical ResearchLimited Human EvidenceLong Term Safety Unknown
Updated August 2026/4 min read/1 citations
Reviewed by the NootropicsIndex editorial team.Method: prioritize cited human research and official safety or regulatory sources; compare retailer-listed prices without endorsing products.Affiliate disclosure
01

What is it?

Identity and form

1

Nicotinamide riboside (NR) is a nicotinamide-derived NAD precursor.

02

Names, aliases and forms

AbbreviationNR
Common NameNicotinamide riboside
03

Mechanisms of action

Biological role

1

Oral NR can increase NAD-related biomarkers, but biomarker change is not the same as a demonstrated clinical or cognitive benefit.

04

Potential effects and evidence map

Human evidence is limited and form-specific. Biochemical plausibility or disease-population studies do not establish a general focus, memory, energy, or healthy-aging benefit for healthy users.

Effect domainMagnitudeGrade
Mental energy / wakefulness1
UnknownConfidence: Medium

Evidence does not establish a reliable mental-energy effect from extra Nicotinamide Riboside in well-nourished healthy adults.

Note Essential nutrient biology and correction of inadequate status are different from enhancement.

0/5
C
Memory / learning1
UnknownConfidence: Medium

Direct evidence does not establish a general memory or learning benefit from Nicotinamide Riboside for healthy adults.

Note Keep form- and population-specific clinical research separate.

0/5
C
05

Timing & effect horizon

Effect horizonUnknown
Unknown
What timing evidence can show1

No reliable acute nootropic onset, duration, The time for blood levels to fall by half during the final elimination phase.Source claim, or routine cycle is established for Nicotinamide Riboside. Nutrient-status correction and clinical follow-up periods answer different questions.

06

Safety, side effects and risk profile

Evidence uncertainty1
Confidence: High

Marketing claims extend beyond the established nutrient or precursor evidence.

Note Separate adequacy, biochemical activity, and enhancement outcomes.

2/5
B
Interaction risk1
Confidence: Medium

Medication, laboratory, and total-intake context can change the practical risk.

Note Check the official source for ingredient-specific interaction details.

1/5
B
GI discomfort1
Confidence: Medium

Tolerability varies with the specific form and amount consumed.

Note This row summarizes ordinary tolerability rather than special-population hazards.

1/5
B
Dose- and form-specific safety1

Human trials suggest generally acceptable short-term tolerability across studied doses, but clinically relevant benefits and long-term healthy-user safety remain uncertain. Safety during pregnancy and lactation has not been established; avoid extrapolating short general-adult trials to these populations.

07

Interactions and cautions

Medication and test context1

Interaction data are limited; high-dose disease trials should not be converted into routine supplement guidance.

08

Practical buying and quality notes

  • Compare the exact NR salt, studied amount, trial duration, and safety monitoring rather than relying on “cellular energy” claims.1
09

FAQ

What distinguishes Nicotinamide Riboside from related forms?

1

NR is distinct from niacinamide and NMN; the available human trials are short and report few consistent clinically relevant outcomes.

10

References

  1. Jensen JB et al. What is really known about the effects of nicotinamide riboside supplementation in humans. 2023.
Note

This page is informational and summarizes available evidence. It is not medical advice, a recommendation, or a substitute for guidance from a qualified clinician.